Myriad Genetics, Inc. earnings per share and revenue

MYGN earnings per share for the last quarter are 0.05 USD whereas the estimation was -0.01 USD which accounts for 528.56% surprise. Company revenue for the same period amounts to 211.50 M USD despite the estimated figure of 206.44 M USD. Estimated earnings per share for the next quarter are 0.02 USD, and revenue is expected to reach 210.76 M USD. Also watch annual changes over time to get a bigger picture of MYGN earnings per share and revenue dynamics.